The Limits of Disclosure: What Research Subjects Want to Know about Investigator Financial Interests
- 1 January 2006
- journal article
- Published by Cambridge University Press (CUP) in Journal of Law, Medicine & Ethics
- Vol. 34 (3) , 592-599
- https://doi.org/10.1111/j.1748-720x.2006.00073.x
Abstract
Concerns about the influence of financial interests on research have increased, along with research dollars from pharmaceutical and other for-profit companies. Researchers’ financial ties to industry sponsors of research have also increased. Financial interests in biomedical research could influence research design, conduct, or reporting, and could compromise data integrity, participant safety, or both. Investigators’ financial ties with for-profit companies may influence reported scientific results, and may have compromised research participant safety.Disclosure is one commonly accepted method of managing financial relationships in order to minimize possible threats to scientific objectivity, the safety of research participants, or public trust in the integrity of clinical research. Disclosure is presumed useful to the extent that “it gives those who would be affected, or who are otherwise in a good position to assess the risks, information they need to make their own decision.”Keywords
This publication has 20 references indexed in Scilit:
- Financial Anatomy of Biomedical ResearchJAMA, 2005
- Potential research participants’ views regarding researcher and institutional financial conflicts of interestJournal of Medical Ethics, 2004
- Expanding Disclosure of Conflicts of Interest: The Views of StakeholdersIRB: Ethics & Human Research, 2003
- Assessing Faculty Financial Relationships With IndustryJAMA, 2000
- Uneasy Alliance — Clinical Investigators and the Pharmaceutical IndustryNew England Journal of Medicine, 2000
- Money is putting people at risk in biomedical research.2000
- Beyond conflict of interestBMJ, 1998
- Financial Interest and Its Disclosure in Scientific PublicationsJAMA, 1998
- Why Review Articles on the Health Effects of Passive Smoking Reach Different ConclusionsJAMA, 1998
- An Ethical Debate: Financial ties as part of informed consent to postmarketing research Attitudes of American doctors and patientBMJ, 1995